Chinese Journal of Respiratory and Critical Care Medicine
Supervisor：Ministry of Education of the People's Republic of ChinaSponsor：West China Medical Center & West China Hospital, Sichuan University Editor-in-chief：LIN Jiangtao / LIU Chuntao Publishing period：
Monthly
ISSN：1671-6205CN：51-1631/R
Citation：王甜, 王可. 免疫治療聯合化學治療的新輔助治療后肺鱗癌獲得病理完全緩解一例. Chinese Journal of Respiratory and Critical Care Medicine, 2021, 20(6): 444-446. doi: 10.7507/1671-6205.202012065Copy
Copyright ? the editorial department of Chinese Journal of Respiratory and Critical Care Medicine of West China Medical Publisher. All rights reserved
1.
Pisters KM, Le Chevalier T. Adjuvant chemotherapy in completely resected non-small-cell lung cancer. J Clin Oncol, 2005, 23(14): 3270-3278.
2.
Burdett S, Stewart L, Auperin A, et al. Chemotherapy in non small cell lung cancer: an update of an individual patient data meta analysis. J Clin Oncol, 2005, 23(4): 924-926.
3.
Pataer A, Kalhor N, Correa AM, et al. Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy. J Thorac Oncol, 2012, 7(5): 825-832.
4.
Cascone T, Gold KA, Swisher SG, et al. Induction cisplatin docetaxel followed by surgery and erlotinib in non- small cell lung cancer. Ann Thorac Surg, 2018, 105(2): 418-424.
5.
Provencio-Pulla M, Nadal-Alforja E, Cobo M, et al. Neoadjuvant chemo /immunotherapy for the treatment of stages ⅢA resectable non-small cell lung cancer (NSCLC): A phase Ⅱ multicenter exploratory study—NADIM study-SLCG. J Clin Oncol, 2018, 36(15): 8521.
6.
Shu C, Grigg C, Chiuzan C, et al. Neoadjuvant atezolizumab + chemotherapy in resectable non-small cell lung cancer (NSCLC). J Clin Oncol, 2018, 36: 8532.
7.
Kayawake H, Okumura N, Yamanashi K, et al. Non-small cell lung cancer with pathological complete response: predictive factors and surgical outcomes. Gen Thorac Cardiovasc Surg, 2019, 67: 773-781.
8.
Westeel V, Quoix E, Puyraveau M, et al. A randomised trial comparing preoperative to perioperative chemotherapy in early-stage non-small-cell lung cancer (IFCT0002 trial). Eur J Cancer, 2013, 49(12): 2654-2664.
9.
NSCLC Meta-analysis Collaborative Group. Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data. Lancet, 2014, 383(9928): 1561-1571.
10.
Smithy JW, Rosen JE, Gao SJ, et al. Postneoadjuvant adjuvant chemotherapy in resected N1 non-small cell lung cancer with residual nodal disease. J Surg Oncol, 2017, 116(8): 1193-1196.
11.
Mouillet G, Monnet E, Milleron B, et al. Pathologic complete response to preoperative chemotherapy predicts cure in early-stage non-small-cell lung cancer: combined analysis of two IFCT randomized trials. J Thorac Oncol, 2012, 7(5): 841-849.
1. Pisters KM, Le Chevalier T. Adjuvant chemotherapy in completely resected non-small-cell lung cancer. J Clin Oncol, 2005, 23(14): 3270-3278.
2. Burdett S, Stewart L, Auperin A, et al. Chemotherapy in non small cell lung cancer: an update of an individual patient data meta analysis. J Clin Oncol, 2005, 23(4): 924-926.
3. Pataer A, Kalhor N, Correa AM, et al. Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy. J Thorac Oncol, 2012, 7(5): 825-832.
4. Cascone T, Gold KA, Swisher SG, et al. Induction cisplatin docetaxel followed by surgery and erlotinib in non- small cell lung cancer. Ann Thorac Surg, 2018, 105(2): 418-424.
5. Provencio-Pulla M, Nadal-Alforja E, Cobo M, et al. Neoadjuvant chemo /immunotherapy for the treatment of stages ⅢA resectable non-small cell lung cancer (NSCLC): A phase Ⅱ multicenter exploratory study—NADIM study-SLCG. J Clin Oncol, 2018, 36(15): 8521.
6. Shu C, Grigg C, Chiuzan C, et al. Neoadjuvant atezolizumab + chemotherapy in resectable non-small cell lung cancer (NSCLC). J Clin Oncol, 2018, 36: 8532.
7. Kayawake H, Okumura N, Yamanashi K, et al. Non-small cell lung cancer with pathological complete response: predictive factors and surgical outcomes. Gen Thorac Cardiovasc Surg, 2019, 67: 773-781.
8. Westeel V, Quoix E, Puyraveau M, et al. A randomised trial comparing preoperative to perioperative chemotherapy in early-stage non-small-cell lung cancer (IFCT0002 trial). Eur J Cancer, 2013, 49(12): 2654-2664.
9. NSCLC Meta-analysis Collaborative Group. Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data. Lancet, 2014, 383(9928): 1561-1571.
10. Smithy JW, Rosen JE, Gao SJ, et al. Postneoadjuvant adjuvant chemotherapy in resected N1 non-small cell lung cancer with residual nodal disease. J Surg Oncol, 2017, 116(8): 1193-1196.
11. Mouillet G, Monnet E, Milleron B, et al. Pathologic complete response to preoperative chemotherapy predicts cure in early-stage non-small-cell lung cancer: combined analysis of two IFCT randomized trials. J Thorac Oncol, 2012, 7(5): 841-849.
Click the content below to copy and paste a set citation format。
Citation：王甜, 王可. 免疫治療聯合化學治療的新輔助治療后肺鱗癌獲得病理完全緩解一例. Chinese Journal of Respiratory and Critical Care Medicine, 2021, 20(6): 444-446. doi: 10.7507/1671-6205.202012065
1/5
WeChat